leadf
logo-loader
viewDirecta Plus PLC

Directa Plus says revenues and orders rise at environmental arm Setcar

Giulio Cesareo, Directa Plus chief executive said: "We are delighted with the performance of Setcar"

Directa Plus PLC -

Directa Plus PLC (LON:DCTA) said its oil spill clean-up business Setcar has seen significantly improved results this year so far.   

The graphene specialist said 51%-owned Setcar’s revenue had risen to €3mln from €2.6mln in the period January 1 to October 1, 2020, despite coronavirus (COVID-19 headwinds.

Over that period, Setcar had won 132 new contracts and been awarded 32 out of 77 tenders, Directa noted.

Setcar’s contracted orders are now expected to generate revenue of €4mln during 2021 and €3mln during 2022.

In a statement, Giulio Cesareo, Directa Plus chief executive said: "We are delighted with the performance of Setcar. Since acquiring the company, our strategy has been to capture new high potential business opportunities leveraging on our patented Grafysorber technology and we are now working to expand Setcar's product offer with the addition of our other G+ products.

 “This success is a reflection of the growing strength of Directa Plus in the environmental vertical.”

Quick facts: Directa Plus PLC

Price: 81.8 GBX

AIM:DCTA
Market: AIM
Market Cap: £50.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Directa Plus PLC named herein, including the promotion by the Company of Directa Plus PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

4 days, 7 hours ago

2 min read